During the past decade, Northeast Clinical Research of San Antonio, LLC conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 11 clinical trials were completed, i.e. on average, 91.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northeast Clinical Research of San Antonio, LLC" #1 sponsor was "Pfizer" with 5 trials, followed by "Gan and Lee Pharmaceuticals, USA" with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast Clinical Research of San Antonio, LLC" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Northeast Clinical Research of San Antonio, LLC" are "Diabetes Mellitus, Type 2" (3 trials), "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 1" (2 trials), "Diabetic Kidney Disease" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Northeast Clinical Research of San Antonio, LLC" in a lesser frequency.

Most popular intervention types in "Northeast Clinical Research of San Antonio, LLC" are "Drug" (13 trials), "Biological" (4 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Gan & Lee Insulin Glargine Injection" (2 trials), "Lantus®" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "180 mg/kg Alpha1-PI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northeast Clinical Research of San Antonio, LLC" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Northeast Clinical Research of San Antonio, LLC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Northeast Clinical Research of San Antonio, LLC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Northeast Clinical Research of San Antonio, LLC, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".